Announcements Trials
Browse Landscape

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 3Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neoplasm Metastasis 1Lung Neoplasms 1Hip Fractures 1Glioma 1Glioblastoma 1Fractures, Spontaneous 1Financial Stress 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1COVID-19 1Brain Neoplasms 1Bone Neoplasms 1Ataxia Telangiectasia 1

Interventions

pembrolizumab 38Bevacizumab 23Cyclophosphamide 22Standard of Care 18Blood Specimen Collection 17Carboplatin 16Paclitaxel 15Nivolumab 14Gemcitabine 14Pemetrexed 13Exercise 13Cisplatin 12atezolizumab 11Radiotherapy 11Fluorouracil 11Doxorubicin 11Surveys and Questionnaires 9Rituximab 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Cetuximab 9Biopsy 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Docetaxel 8olaparib 7Temozolomide 7Prednisone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Data Collection × 90 days × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT00684580 2026-04-29

Protocol For Collecting Data On Patients With Childhood Cancer

St. Jude Children's Research Hospital

Recruiting
30,000 enrolled
Tumor-Agnostic

Neoplasms

NCT04477681 2026-03-31

SACHA

Gustave Roussy, Cancer Campus, Grand Paris

Recruiting
1,150 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡